ASUS to Present Transformative AI Infrastructure Solutions at NVIDIA GTC 2025 as Diamond Sponsor
TAIPEI, Feb. 24, 2025 /PRNewswire/ -- ASUS today announced its participation as a Diamond Sponsor at NVIDIA GTC 2025 at booth #1523 from March 17–21 in San Jose, USA. At this premier AI conference, ASUS will showcase its latest advancements in AI infrastructure underscoring its vision of Ubiquitous AI. Incredible Possibilities.
Led by Chairman Jonney Shih and Co-CEO S.Y. Hsu, ASUS will present a comprehensive range of AI and IoT solutions, including high-performance servers, intelligent edge computing, advanced cooling technologies, and software innovations designed to meet the demands of AI-powered workloads.
ASUS leads in AI supercomputing with an integrated hardware-software approach, building a comprehensive AI ecosystem to enhance inferencing, training, and workload management. As a Diamond Sponsor at GTC25, ASUS reinforces its commitment to delivering scalable, efficient AI infrastructure that accelerates adoption, reduces total cost of ownership (TCO), and drives innovation. With strategic partnerships and a growing HPC/AI ecosystem, ASUS empowers enterprises with seamless, end-to-end solutions for diverse AI workloads.
ASUS AI POD with NVIDIA GB200 NVL72 to ship in March
Strengthening its position at the forefront of AI infrastructure, ASUS announced that the ASUS AI POD featuring the NVIDIA GB200 NVL72 platform is set to be shipped in March 2025. Utilizing the NVIDIA GB200 Grace Blackwell Superchip and fifth-generation NVIDIA NVLink interconnect technology, ASUS AI POD offers remarkable performance and energy efficiency, making it ideal for tasks ranging from training trillion-parameter language models to performing real-time AI inference.
Learn more here: ASUS AI POD with NVIDIA GB200 NVL72
Join ASUS at GTC 2025
To explore how ASUS AI solutions can support your business in achieving greater innovation and efficiency, stop by booth #1523 at NVIDIA GTC 2025 from March 18–21 in San Jose. ASUS looks forward to connecting with visitors at GTC 2025 and sharing how its collaboration with NVIDIA can drive AI advancement across industries.
About ASUS
ASUS is a global technology leader that provides the world's most innovative and intuitive devices, components, and solutions to deliver incredible experiences that enhance the lives of people everywhere. With its team of 5,000 in-house R&D experts, the company is world-renowned for continuously reimagining today's technologies. Consistently ranked as one of Fortune's World's Most Admired Companies, ASUS is also committed to sustaining an incredible future. The goal is to create a net zero enterprise that helps drive the shift towards a circular economy, with a responsible supply chain creating shared value for every one of us.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
4 minutes ago
- Business Insider
What tariffs? S&P 500 companies are wrapping up one of the strongest earnings seasons on record.
Second-quarter earnings season is almost over and it's been much better than investors had feared going into it. The big lesson so far? Tariffs aren't yet weighing on companies' bottom line. When President Donald Trump began implementing tariffs early in 2025, it sparked concerns that the import duties would result in a hit to earnings growth. Yet, while uncertainty remains elevated, S&P 500 companies are wrapping up a stellar season of quarterly reports. In an August 15 note to investors, Goldman Sachs analyst David Kostin said that companies in the benchmark index had shown more resilient profit margins than many expected, helped in a big way by the steady weakening of the US dollar this year, which has helped drive sales growth overseas. "Corporations have continued to message their ability to maintain their margins by negotiating with suppliers, adjusting supply chains, passing through prices to consumers, and cutting other costs," Kostin said. Indeed, this earnings season, 58% of companies increased their full-year guidance for 2025, doubling the number from the first quarter. Aggregate S&P 500 earnings rose 11% on a year-over-year (YOY) basis, almost 3x the consensus expectation of 4%, and 84% of companies overall have beaten Wall Street's estimates. "With the 2Q 2025 earnings season nearly complete, the quarter has been marked by one of the greatest frequency of earnings beats on record," Kostin said. While Nvidia doesn't report earnings until August 27, its Magnificent 7 peers reported mostly strong results, excluding Tesla, which saw a steep decline in year-over-year revenue. "Earnings results have continued to be exceptional for the mega-cap tech companies," Kostin wrote. "The Magnificent 7 apparently grew EPS by 26% year/year in 2Q, a 12% beat relative to consensus expectation coming into earnings season." They see this trend as likely to continue, noting that analyst estimates predict nominal sales growth will remain roughly stable for both large and small-mid cap companies through the end of 2025. Kostin and his team said that while they expect to see many S&P 500 companies maintain high profit margins in the coming quarters, they see analyst margin forecasts for 2026 as overly optimistic. "While companies remain confident in their ability to mitigate the cost pressures imposed by tariffs, and arithmetically the superior margins of the largest technology companies should continue to boost margins for the aggregate index, we see little reason to expect a large increase in profit margins next year."
Yahoo
26 minutes ago
- Yahoo
JETSET Pilates Sets Sights on Chicagoland as Next Hot Market for Franchise Growth
With studios planned for Naperville and Winnetka, the fast-growing Pilates franchise eyes strategic expansion in top Chicago neighborhoods MIAMI, Aug. 18, 2025 /PRNewswire/ -- JETSET Pilates, a fast-growing modern Reformer Pilates franchise offering premium, full-body workouts, is ramping up its Chicagoland expansion with two initial locations confirmed in Naperville and Winnetka, and plans to strategically open 10–12 studios across the region over the next several years. The brand is actively targeting premier neighborhoods in and around Chicago, including Lincoln Park, River North, and the Gold Coast, as well as affluent suburbs such as Evanston, Oak Brook, and Hinsdale. With Chicago ranking #8 on the 2024 Mindbody + ClassPass Wellness Index as one of the nation's healthiest cities, JETSET is poised to meet the region's strong appetite for high-end workout concepts. "Chicago is a city that thrives on innovation, style, and energy, and that's exactly what JETSET delivers," said Bert Albertse, CEO of JETSET Pilates. "From our curated playlists to our studio design, every detail is built to inspire. We see a clear opportunity to make JETSET a go-to fitness destination here, and we're ready to grow alongside the city's community." JETSET's record-setting growth in 2025 includes the opening of 16 new studios in the first half of the year, entry into new U.S. markets, and its first international location in Melbourne, Australia. With more than 160 locations sold and in development, the brand continues to attract interest from franchise partners in top-tier markets like Chicago. "Launching new locations in Naperville and Winnetka is just the beginning," said Tamara Galinsky, Founder and Brand President of JETSET Pilates. "We're actively seeking passionate franchise partners in Chicagoland who share our vision of delivering a premium Pilates experience that meets the city's growing demand for innovative fitness solutions." Since launching its franchise opportunity in 2022, JETSET Pilates has quickly become one of the fastest-growing concepts in the boutique fitness sector. For more information about JETSET Pilates and its franchise opportunities, visit About JETSET Pilates Founded in 2010 and franchising since 2022, JETSET Pilates has rapidly established itself as one of the most attractive concepts in the boutique franchise business space. JETSET Pilates currently has plans to open studios across the U.S. and Australia, with 160 studios in development. JETSET now offers franchising opportunities to entrepreneurs in some of the largest and fastest-growing markets within the fitness franchise sector. For more information, please visit or follow JETSET Pilates on LinkedIn and Instagram. Contact: Elise Fricilone | Franchise Elevator | efricilone@ View original content to download multimedia: SOURCE JETSET Pilates Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Nuclear Medicine Equipment Market worth $8.31 billion by 2030 with 4.62% CAGR
DELRAY BEACH, Fla., Aug. 18, 2025 /PRNewswire/ -- The global Nuclear Medicine Equipment Market, valued at US$6.33 billion in 2024, stood at US$6.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.62% from 2025 to 2030, culminating in a forecasted valuation of US$8.31 billion by the end of the period. The growth of this market is primarily accelerated by the increasing prevalence of cancer and cardiovascular diseases, rising demand for early and precise diagnostic imaging, and increased use of hybrid imaging devices such as PET/CT and SPECT/CT. Moreover, the convergence of AI-based imaging software and the establishment of nuclear medicine facilities in emerging economies is creating new platforms for long-term market development. Download PDF Brochure: Browse in-depth TOC on "Nuclear Medicine Equipment Market" 389 - Tables50 - Figures356 - Pages By product type, the nuclear medicine software segment is the fastest growing in the nuclear medicine equipment market. This is attributed to the increasing adoption of theragnostic-based treatment approaches, which require specialized software for personalized dosimetry, real-time treatment response monitoring, and advanced image fusion, especially in oncology applications involving radioligand therapies like ^177Lu-PSMA and ^177Lu-DOTATATE. The need for specialized software tools is also being accelerated by regulatory changes like the Dosimetry Initiative of the SNMMI and the European Council Directive 2013/59/Euratom, which requires customized treatment planning. Additionally, vendors are implementing AI-powered features that facilitate kinetic modeling, quantitative evaluation, and lesion segmentation, which are quickly becoming crucial in busy cancer clinics and research facilities. By Therapeutic Area, this is due to the rising global prevalence of cancer, estimated to be more than 20 million new cases in 2022 and 35 million by 2050, which has significantly increased demand for early, precise, and functional imaging. Nuclear imaging techniques such as PET/CT and SPECT/CT are essential for cancer detection, staging, treatment planning, and response assessment. In addition, the increasing demand for radioligand therapies like ^177Lu-PSMA in prostate cancer and ^177Lu-DOTATATE in neuroendocrine tumors has increased the demand for advanced imaging systems and oncology-specific software. Innovation in the field of radiopharmaceuticals, regulatory backing for theranostics, and increasing reimbursement for cancer diagnostics have also helped dominate the market for this segment. By geography, this is due to the high-level healthcare infrastructure in the region, extensive use of hybrid imaging modalities like PET/CT and SPECT/CT, and high emphasis on early disease detection and individualized medicine. The US alone performs close to 20 million nuclear medicine procedures every year due to the high incidence of cancer and cardiovascular disease. Moreover, the lucrative reimbursement schemes, large investments in nuclear medicine research, and prominent industry players such as GE Healthcare and Siemens Healthineers are supporting sustained market dominance. Government support for theranostic applications and ongoing clinical trials in radiopharmaceutical treatments further cemented the dominant position of North America. Request Sample Pages : The report profiles key players such as Hermes Medical Solutions (Sweden), DOSIsoft (France), Segami Corporation (US), GE HealthCare (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), and Canon Medical Systems Corporation (Japan). GE HealthCare (US): A global medical technology company became an independent publicly traded entity in January 2023 following its separation from General Electric. The company operates through five main business segments, with its nuclear medicine equipment included under the Imaging segment. It combines SPECT and PET imaging systems with software platforms like Xeleris and AI-powered tools for image reconstruction and workflow support. In 2024, GE HealthCare acquired MIM Software to expand its molecular imaging and radiation oncology capabilities, which included image analysis and quantification tools used in clinical settings such as oncology, cardiology, and neurology. With over 50 manufacturing and R&D facilities, GE HealthCare serves hospitals, diagnostic centers, and research institutions in more than 160 countries. Siemens Healthineers AG (Germany) A prominent medical technology company provides a wide range of products and solutions in laboratory diagnostics, healthcare IT, and diagnostic and therapeutic imaging. Its portfolio, which serves hospitals, diagnostic labs, outpatient clinics, and academic institutions globally, includes MRI, CT, PET, SPECT systems, laboratory automation technologies, and cutting-edge digital tools for clinical decision support. The company's nuclear medicine products are under the Imaging segment, specifically under Molecular Imaging, of its four primary business segments: Imaging, Diagnostics, Varian (Advanced Therapies), and Services. It is known for its high-end PET/CT and SPECT/CT systems, which include flagship products such as Biograph PET/CT and Biograph mMR PET/MR hybrids. These systems are complemented by software platforms such as MI Applications and Syngo Via, which facilitate workflow optimization, image quantification, and hybrid imaging through automation and multimodality integration. Nuclear medicine departments, oncology and cardiology clinics, and research institutions use these solutions extensively in oncology, neurology, and cardiac imaging. It has a significant global presence in the medical imaging market due to its operations in more than 70 countries and global manufacturing footprint in Europe, the Americas, and Asia Pacific. For more information, Inquire Now! Related Reports: Radiation Detection, Monitoring & Safety Market Nuclear Medicine Market Electroceuticals Market Diagnostic Imaging Market Medical Radiation Detection Market Get access to the latest updates on Nuclear Medicine Equipment Companies and Nuclear Medicine Equipment Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
